World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
41815
World Ranking
6757
National Ranking
3566

Overview

Sherry Pierce is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research predominantly centers on hematologic malignancies, with a focus on acute myeloid leukemia and related disorders.

Their recent published works include the following papers:

  • Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia, 2021, Blood Cancer Journal
  • Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality, 2020, American Journal of Hematology
  • Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia, 2021, Blood Advances
  • Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias, 2020, Acta Haematologica
  • The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia, 2020, Leukemia

Frequent collaborators include:

  • Tapan M. Kadia
  • Hagop M. Kantarjian
  • Guillermo Garcia-Manero
  • Farhad Ravandi
  • Courtney D. DiNardo

Sherry Pierce's work appears consistently in several key publication venues, notably:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • American Journal of Hematology
  • HemaSphere
  • Journal of Clinical Oncology

Their main field of study is Medicine, with a substantial emphasis on subfields such as Hematology, Genetics, Molecular Biology, Oncology, and Public Health, Environmental and Occupational Health.

Their research extensively covers topics including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Acute Lymphoblastic Leukemia research

Best Publications

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

    Hagop Kantarjian;Deborah Thomas;Susan O'Brien;Jorge Cortes

  • Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

    Deborah A. Thomas;Stefan Faderl;Jorge Cortes;Susan O'Brien

  • Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

    Deborah A. Thomas;Stefan Faderl;Susan O'Brien;Carlos Bueso-Ramos

  • Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

    Hui Yang;Carlos Bueso-Ramos;Courtney DiNardo;Marcos R Estecio

  • Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy

    Hagop M. Kantarjian;Terry L. Smith;Susan O'Brien;Miloslav Beran

  • New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

    Julie Schanz;Heinz Tüchler;Francesc Solé;Mar Mallo

  • Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

    Andres O. Soriano;Hui Yang;Stefan Faderl;Zeev Estrov

  • Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia

    Deborah A. Thomas;Susan O'Brien;Stefan Faderl;Guillermo Garcia-Manero

  • Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

    Alfonso Quintás-Cardama;Hagop Kantarjian;Taghi Manshouri;Rajyalakshmi Luthra

  • Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.

    Naval Daver;Guillermo Garcia-Manero;Sreyashi Basu;Prajwal C Boddu

  • Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

    Farhad Ravandi;Eli Estey;Dan Jones;Stefan Faderl

  • Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.

    Hagop M. Kantarjian;Farhad Ravandi;Susan OBrien;Jorge Cortes

  • Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

    Farhad Ravandi;Mona Lisa Alattar;Michael R. Grunwald;Michelle A. Rudek

  • DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes

    Lanlan Shen;Hagop Kantarjian;Yi Guo;E. Lin

  • A prognostic score for patients with lower risk myelodysplastic syndrome.

    G. Garcia-Manero;J. Shan;S. Faderl;J. Cortes

  • Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

    Roland B. Walter;Roland B. Walter;Megan Othus;Gautam Borthakur;Farhad Ravandi

  • Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults

    Nitin Jain;Kathryn G. Roberts;Elias Jabbour;Keyur Patel

  • Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia

    Deborah A. Thomas;Jorge Cortes;Susan O'Brien;Sherry Pierce

  • Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.

    Nitin Jain;Audrey V. Lamb;Susan O’Brien;Farhad Ravandi

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a wide range of medical and healthcare career opportunities. For those seeking flexible or accelerated study options, online and fast-track programs can be a great choice.

Nursing is a popular career pathway, and programs like the lpn fast track program allow students to join the healthcare workforce quickly. Those looking to advance further may consider finding the shortest dnp program to earn a doctorate in nursing practice efficiently.

Mental health is another critical field. Practicing nurses interested in this specialty can enroll in the shortest online pmhnp programs for psychiatric-mental health nurse practitioner credentials.

For those more inclined toward leadership and management roles, pursuing one of the best online mha programs in healthcare administration offers an affordable and flexible route to high-demand positions.

Exploring these options can help students match their goals, timelines, and budgets, ensuring a rewarding healthcare career.

Best Scientists Citing Sherry Pierce

Trending Scientists

Recently Published Articles